A startup called Ambrosia will fill your veins with the blood of young people and empty your pockets of $8,000

Quick Read

Ana Santos Rutschman: “As an FDA scholar at the Jaharis Health Law Institute at DePaul, I worry that faster regulatory review and approval might come at a cost. We may sacrifice safety and efficacy of drugs and devices approved under this new system”

Quick Read

Federal officials today released a plan to help US agencies decide whether to fund controversial studies that make viruses more dangerous. The guidance may finally bring an end to a moratorium that has kept a handful of experiments funded by the Department of Health and Human Services (HHS) on hold for more than 2 years

Quick Read

After the director of its Wellness Institute was forced to walk back an anti-vaccine blog post over the weekend, the Cleveland Clinic revealed Monday that it has already spent months reevaluating the institute’s focus and expects to halt the sale of some alternative medicine products

Quick Read

Ohio Gov. John Kasich signed a 20-week gestation limit for abortions into law Tuesday, while separately vetoing a measure that would have banned abortions after a fetal heartbeat is detectable

Quick Read

Reshma Ramachandran and our Zackary Berger voice concerns about the impact of the 21st Century Cures Act on the FDA should it become law

Quick Read

Earlier this evening, the House of Representatives released the most recent draft of the 21st Century Cures Act, which has ballooned from a 200-page discussion draft in April 2015 to a 996-page draft version today

Quick Read

“It is just not possible to effectively monitor every communicable disease in real time with human eyes alone,” Sharon Greene said. “To be able to quickly and effectively and precisely detect an outbreak, to kick off an outbreak investigation process — the earlier that you can begin this it helps to limit sickness, it helps to limit death, and it makes it more likely that you will successfully solve the outbreak

Quick Read